(4S,5S)-2,2-Dimethyl-4-phenyl-3,5-oxazolidinedicarboxylic acid, 3-(1,1-dimethylethyl) ester is a chiral oxazolidine derivative. It serves as a key chiral auxiliary and building block in asymmetric synthesis. The compound features a rigid, well-defined stereogenic center, making it valuable for inducing stereoselectivity in chemical reactions. Its primary application is in the pharmaceutical industry as a chiral intermediate for the synthesis of active pharmaceutical ingredients (APIs). The oxazolidine ring system is a privileged scaffold found in various bioactive molecules. This specific compound, with its tert-butyl ester group, is utilized in the synthesis of complex molecules where control of absolute stereochemistry is critical, particularly in the development of drugs targeting the central nervous system or as a precursor to other chiral ligands and catalysts. While its main use is as a specialized pharmaceutical intermediate, its well-defined structure also qualifies it as a chiral organic synthesis building block for research purposes in academic and industrial laboratories focused on method development and the construction of enantiomerically pure compounds.